Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v3-EN
Language English English
Date Updated 2022-06-04 2022-06-04
Drug Identification Number 02410419 02410419
Brand name IRINOTECAN IRINOTECAN
Common or Proper name IRINOTECAN IRINOTECAN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients IRINOTECAN HYDROCHLORIDE IRINOTECAN HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 15mL 15mL
ATC code L01CE L01CE
ATC description
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date
Actual discontinuation date 2022-06-03 2022-06-03
Remaining supply date 2022-06-03 2022-06-03
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments